Answers are grounded in this paper and cite their sources.
Neurotransmitter receptors are involved in cancer progression. Among them, the heterodimeric GABA B receptor, activated by the main inhibitory neurotransmitter GABA, is composed of the transmembrane GABA B1 and GABA B2 subunits. The oncogenic role of the isoform GABA B1e (GB 1e ) containing only the extracellular domain of GABA B1 remains unclear. We revealed that GB 1e is largely expressed in human breast cancer (BrCa) cell lines as well as in BrCa tissues where it is upregulated. Moreover, GB 1e promoted the malignancy of BrCa cells both in vitro and in vivo . We propose that GB 1e favors EGFR signaling by interacting with PTPN12 to disrupt the interaction between EGFR and PTPN12, and phosphorylation of Y230 and Y404 on GB 1e is required in this process. Our data highlight that the GABBR1 gene through the expression of the GB 1e isoform might play an important oncogenic role in BrCa and that GB 1e is of interest for the treatment of some cancers.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: